Breast Disease pp 371-383 | Cite as

Nonepithelial Malignancies of the Breast

  • Gursel Remzi Soybir


Breast sarcomas are rare clinical entities. The symptoms are similar to other breast malignancies, and diagnosis depends on conventional triple assessment. However, their biology and prognosis are closer to those of soft tissue sarcomas than to invasive breast cancers. Surgical excision with clear margins is the primary treatment for localized tumors. Lymph node sampling and dissection is not recommended. Adjuvant or neoadjuvant therapy should be considered for high-risk patients. Postoperative radiotherapy shows a small survival advantage, and response rates for systemic therapies are poor. Angiosarcomas are the most common sarcomas of the breast. They can be associated with lymphedema or irradiation. Surgery is the primary treatment, and wide negative margins are essential for a long-term cure. The potential for local recurrence and distant metastasis are high. Leiomyosarcoma, liposarcoma, rhabdomyosarcoma, and fibrosarcoma are the other rare sarcoma subtypes in the breast. Primary breast lymphoma is a rare entity that arises from the periductal and perilobular lymphatic tissue and intramammary lymph nodes. The breast is the first major site of manifestations without any evidence of concurrent systemic disease. A painless, mobile, rapidly enlarging mass is a common clinical presentation. Primary breast lymphomas are sensitive to chemotherapy and radiotherapy. Surgery is limited to biopsy. The clinical stage and histological subtype are the main prognostic factors. Metastatic involvement of the breast most often originates from the contralateral site. The most common malignancy of the body that metastasizes to the breast is malignant melanoma. Hematological malignancies such as leukemia and lymphoma also frequently occur. Comprehensive screening is necessary to identify the origin of the primary tumor.


Breast Breast cancer Sarcoma Molecular pathogenesis Postirradiation sarcomas Post-radiotherapy Breast lymphoma Epidemiology Etiology Subgroups Symptoms Diagnosis Clinical characteristics Radiologic imagination Histological diagnosis Staging Treatment Axillary approach Surgery Surgical outcome Adjuvant therapy Neoadjuvant therapy Adjuvant radiotherapy Adjuvant chemotherapy Survival Prognosis Angiosarcoma Fibrosarcoma Leiomyosarcoma Liposarcoma Rhabdomyosarcoma Li-Fraumeni syndrome Cowden disease 


  1. 1.
    Voutsadakis IA, Zaman K, Leyvraz S. Breast sarcomas: current and future perspectives. Breast. 2001;20:199–204.CrossRefGoogle Scholar
  2. 2.
    Nizri E, Merimsky O, Lahat G. Optimal management of sarcomas of the breast: an update. Expert Rev Anticancer Ther. 2014;14:705–10.PubMedCrossRefGoogle Scholar
  3. 3.
    Pencavel TD, Hayes A. Breast sarcoma – a review of diagnosis and management. Int J Surg. 2009;7:20–3.PubMedCrossRefGoogle Scholar
  4. 4.
    Pollard SG, Marks PV, Temple LN, Thompson HH. Breast sarcoma. A clinicopathologic review of 25 cases. Cancer. 1990;66(5):941–4.PubMedCrossRefGoogle Scholar
  5. 5.
    Lim SZ, Ong KW, Tan BK, Selvarajan S, Tan PH. Sarcoma of the breast: an update on a rare entity. J Clin Pathol. 2016;69(5):373–81.PubMedCrossRefGoogle Scholar
  6. 6.
    Balzer BL, Weiss SW. Do biomaterials cause implant-associated mesenchymal tumors of the breast? Analysis of 8 new cases and review of the literature. Hum Pathol. 2009;40:1564–70.PubMedCrossRefGoogle Scholar
  7. 7.
    Yap J, Chuba PJ, Thomas R, Aref A, Lucas D, Severson RK, et al. Sarcoma as a second malignancy after treatment for breast cancer. Int J Rad Oncol Biol Phys. 2002;52:1231–7.CrossRefGoogle Scholar
  8. 8.
    Kirova YM, Vilcoq JR, Asselain B, Sastre-Garau X, Fourquet A. Radiation-induced sarcomas after radiotherapy for breast carcinoma. Cancer. 2005;104:856–63.PubMedCrossRefGoogle Scholar
  9. 9.
    Blanchard DK, Reynolds C, Grant CS, Farley DR, Donohue JH. Radiation-induced breast sarcoma. Am J Surg. 2002;184:356–8.PubMedCrossRefGoogle Scholar
  10. 10.
    Mery CM, George S, Bertagnolli MM, Raut CP. Secondary sarcomas after radiotherapy for breast cancer: sustained risk and poor survival. Cancer. 2009;115:4055–63.PubMedCrossRefGoogle Scholar
  11. 11.
    Adem C, Reynolds C, Ingle JN, Nascimento AG. Primary breast sarcoma: clinicopathologic series from the Mayo Clinic and review of the literature. Br J Cancer. 2004;91:237–41.PubMedPubMedCentralCrossRefGoogle Scholar
  12. 12.
    McGowan TS, Cummings BJ, O’Sullivan B, Catton CN, Miller N, Panzarella T. An analysis of 78 breast sarcoma patients without distant metastases at presentation. Int J Radiat Oncol Biol Phys. 2000;46:383–90.PubMedCrossRefGoogle Scholar
  13. 13.
    Bousquet G, Confavreux C, Magné N, Tunonde LC, Poortmans P, Senkus E, et al. Outcome and prognostic factors in breast sarcoma: a multicenter study from the rare cancer network. Radiother Oncol. 2007;85:355–61.PubMedCrossRefGoogle Scholar
  14. 14.
    Pandey M, Mathew A, Abraham EK, Rajan B. Primary sarcoma of the breast. J Surg Oncol. 2004;87:121–5.PubMedCrossRefGoogle Scholar
  15. 15.
    Fields RC, Aft RL, Gillanders WE, Eberlein TJ, Margenthaler JA. Treatment and outcomes of patients with primary breast sarcoma. Am J Surg. 2008;196:559–61.PubMedCrossRefGoogle Scholar
  16. 16.
    Hunt KK, Newman LA, Copeland EM III. Bland KI. In: Brunicardi FC, Andersen DK, Billiar TR, Dunn DL, Hunter JG, Matthews JB, Pollock RE, editors. Schwartz’s principles of surgery. 9th ed. New York: The McGraw-Hill Companies; 2010. p. 423–74.Google Scholar
  17. 17.
    Luini A, Gatti G, Diaz J, Botteri E, Oliveira E, Sahiumde C, Almeida R, et al. Angiosarcoma of the breast: the experience of the European Institute of Oncology and a review of the literature. Breast Cancer Res Treat. 2007;105:81–5.PubMedCrossRefGoogle Scholar
  18. 18.
    Nakamura R, Nagashima T, Sakakibara M, Nakano S, Tanabe N, Fujimoto H, et al. Angiosarcoma arising in the breast following breast-conserving surgery with radiation for breast carcinoma. Breast Cancer. 2007;14:245–9.PubMedCrossRefGoogle Scholar
  19. 19.
    Strobbe LJ, Peterse HL, van Tinteren H, Wijnmaalen A, Rutgers EJ. Angiosarcoma of the breast after conservation therapy for invasive cancer, the incidence and outcome. An unforeseen sequela. Breast Cancer Res Treat. 1998;47:101–9.PubMedCrossRefGoogle Scholar
  20. 20.
    Lum YW, Jacobs L. Primary breast sarcoma. Surg Clin N Am. 2008;88:559–70.PubMedCrossRefGoogle Scholar
  21. 21.
    Yang WT, Muttarak M, Ho LW. Non mammary malignancies of the breast: ultrasound, CT, and MRI. Semin Ultrasound CT MR. 2000;21:375–94.PubMedCrossRefGoogle Scholar
  22. 22.
    Yang WT, Hennessy BT, Dryden MJ, Valero V, Hunt KK, Krishnamurthyb S. Mammary angiosarcomas: imaging findings in 24 patients. Radiology. 2007;242:725–34.PubMedCrossRefGoogle Scholar
  23. 23.
    Liberman L, Dershaw DD, Kaufman RJ, Rosen PP. Angiosarcoma of the breast. Radiology. 1992;183:649–54.PubMedCrossRefGoogle Scholar
  24. 24.
    Schnarkowski P, Kessler M, Arnholdt H, Helmberger T. Angiosarcoma of the breast: mammographic, sonographic, and pathological findings. Eur J Radiol. 1997;24:54–6.PubMedCrossRefGoogle Scholar
  25. 25.
    Shahbahang M, Franchesci D, Sundaram M, Castillo MH, Moffat FL, Frank DS, et al. Surgical management of primary breast sarcoma. Am Surg. 2007;68:673–7.Google Scholar
  26. 26.
    Hsu C, McCloskey SA, Peddi PF. Management of Breast Sarcoma. Surg Clin N Am. 2016;96:1047–58.PubMedCrossRefGoogle Scholar
  27. 27.
    Panicek DM, Gatsonis C, Rosenthal DI, Seeger LL, Huvos AG, Moore SG, Caudry DJ, Palmer WE, McNeil BJ. CT and MR imaging in the local staging of primary malignant musculoskeletal neoplasms: report of the Radiology Diagnostic Oncology Group. Radiology. 1997;202:237–46.PubMedCrossRefGoogle Scholar
  28. 28.
    Schwartz HS, Spengler DM. Needle tract recurrences after closed biopsy for sarcoma: three cases and review of the literature. Ann Surg Oncol. 1997;4:228–36.PubMedCrossRefGoogle Scholar
  29. 29.
    Gutman H, Pollock RE, Ross MI, Benjamin RS, Johnston DA, Janjan NA, et al. Sarcoma of the breast: implications for extent of therapy. The M.D. Anderson experience. Surgery. 1994;116:505–9.PubMedGoogle Scholar
  30. 30.
    Callery CD, Rosen PP, Kinne DW. Sarcoma of the breast: a study of 32 patients with reappraisal of classification and therapy. Ann Surg. 1985;201:527–32.PubMedPubMedCentralCrossRefGoogle Scholar
  31. 31.
    Ciatto S, Bonardi R, Cataliotti L, Cardona G. Sarcomas of the breast: a multicenter series of 70 cases. Neoplasma. 1992;39:375–9.PubMedGoogle Scholar
  32. 32.
    Al-Benna S, Poggemann K, Steinau H-U, Steinstraesser L. Diagnosis and management of primary breast sarcoma. Breast Cancer Res Treat. 2010;122:619–26.PubMedCrossRefGoogle Scholar
  33. 33.
    Telli ML, Horst KC, Guardino AE, Dirbas FM, Carlson RW. Phyllodes tumours of the breast: natural history, diagnosis, and treatment. J Natl Compr Cancer Netw. 2007;5:324–30.CrossRefGoogle Scholar
  34. 34.
    Toesca A, Spitaleri G, De Pas T, Botteri E, Gentilini O, Bottiglieri L, Rotmentsz N, Sangalli C, Marrazzo E, Cassano E, Veronesi P, Rietjens M, Luini A. Sarcoma of the breast: outcome and reconstructive options. Clin Breast Cancer. 2012;12:438–44.PubMedCrossRefGoogle Scholar
  35. 35.
    Sher T, Hennessy BT, Valero V, Broglio K, Woodward WA, Trent J, et al. Primary angiosarcomas of the breast. Cancer. 2007;110:173–8.PubMedPubMedCentralCrossRefGoogle Scholar
  36. 36.
    Barrow BJ, Janjan NA, Gutman H, Benjamin RS, Allen P, Romsdahl MM, et al. Role of radiotherapy in sarcoma of the breast. A retrospective review of the M.D. Anderson experience. Radiother Oncol. 1999;52:173–8.PubMedCrossRefGoogle Scholar
  37. 37.
    Warren LE, Miller CL, Horick N, Skolny MN, Jammallo LS, Sadek BT, Shenouda MN, O’Toole JA, MacDonald SM, Specht MC, Taghian AG. The impact of radiation therapy on the risk of lymphedema after treatment for breast cancer: a prospective cohort study. Int J Radiat Oncol Biol Phys. 2014;88:565–71.PubMedPubMedCentralCrossRefGoogle Scholar
  38. 38.
    Kapiris I, Nasiri N, A’Hern R, Healy V, Gui GP. Outcome and predictive factors of local recurrence and distant metastases following primary surgical treatment of high-grade malignant phyllodes tumours of the breast. Eur J Surg Oncol. 2001;27:723–30.PubMedCrossRefGoogle Scholar
  39. 39.
    Fou A, Schnabel FR, Hamele Bena D, Wei XJ, Cheng B, El Tamer M, et al. Long term outcomes of malignant phyllodes tumors patients: an institutional experience. Am J Surg. 2006;192:492–5.PubMedCrossRefGoogle Scholar
  40. 40.
    Ben Hassouna J, Damak T, Gamoudi A, Chargui R, Khomsi F, Mahjoub S, et al. Phyllodes tumours of the breast: a case series of 106 patients. Am J Surg. 2006;192:141–7.PubMedCrossRefGoogle Scholar
  41. 41.
    Reynoso D, Subbiah V, Trent JC, Guadagnolo BA, Lazar AJ, Benjamin R, et al. Neoadjuvant treatment of soft-tissue sarcoma: a multimodality approach. J Surg Oncol. 2010;101:327–33.PubMedCrossRefGoogle Scholar
  42. 42.
    Zelek L, Llombart-Cussac A, Terrier P, Pivot X, Guinebretiere JM, Le Pechoux C, Tursz T, Rochard F, Spielmann M, Le Cesne A. Prognostic factors in primary breast sarcomas: a series of patients with long-term follow-up. J Clin Oncol. 2003;21:2583–8.PubMedCrossRefGoogle Scholar
  43. 43.
    Brennan MF, Singer S, Maki RG. DeVita, Hellman, Rosenberg’s canceprinciples and practice of oncology. Philadelphia: Lippincott Williams and Wilkins; 2008. p. 1741–89.Google Scholar
  44. 44.
    Parker SJ, Harries SA. Phyllodes tumours. Postgrad Med J. 2001;77:428–35.PubMedPubMedCentralCrossRefGoogle Scholar
  45. 45.
    Grimer R, Athanasıu N, Gerrand C, Judson I, Lewis I, Morton B, Peake D. UK Guidelines for the management of soft tissue sarcomas. Sarcoma. 2010;2010:317462.PubMedPubMedCentralGoogle Scholar
  46. 46.
    Lahat G, Lev D, Gerstenhaber F, Madewell J, Le-Petross H, Pollock RE. Sarcomas of the breast. Expert Rev Anticancer Ther. 2012;12:1045–51.PubMedCrossRefGoogle Scholar
  47. 47.
    Linthorst M, van Geel AN, Baartman EA, Oei SB, Ghidey W, van Rhoon GC, van der Zee J. Effect of a combined surgery, re-irradiation and hyperthermia therapy on local control rate in radio-induced angiosarcoma of the chest wall. Strahlenther Onkol. 2013;189:387–93.PubMedCrossRefGoogle Scholar
  48. 48.
    Agulnik M, Yarber JL, Okuno SH, von Mehren M, Jovanovic BD, Brockstein BE, Evens AM, Benjamin RS. An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas. Ann Oncol. 2013;24:257–63.PubMedCrossRefGoogle Scholar
  49. 49.
    Gladdy RA, Qin L-X, Moraco N, Edgar MA, Antonescu CR, Alektiar KM, et al. Do radiation-associated soft tissue sarcomas have the same prognosis as sporadic soft tissue sarcomas? J Clin Oncol. 2010;28:2064–9.PubMedPubMedCentralCrossRefGoogle Scholar
  50. 50.
    Vorburger SA, Xing Y, Hunt KK, Lakin GE, Benjamin RS, Feig BW, et al. Angiosarcoma of the breast. Cancer. 2005;104:2682–8.PubMedCrossRefGoogle Scholar
  51. 51.
    Barth RJ Jr. Histologic features predict local recurrence after breast conserving therapy of phyllodes tumours. Breast Cancer Res Treat. 1999;57:291–5.PubMedCrossRefGoogle Scholar
  52. 52.
    Yoshitani K, Kido A, Honoki K, Fujii H, Takakura Y. Pelvic metastasis of breast synovial sarcoma. J Orthop Sci. 2009;14:219–23.PubMedCrossRefGoogle Scholar
  53. 53.
    Tormo V, Andreu FJ. Primary breast synovial sarcoma: a rare primary breast neoplasia. Clin Transl Oncol. 2009;11:854–5.PubMedCrossRefGoogle Scholar
  54. 54.
    Verweij J, van Oosterom A, Blay J-Y, Judson I, Rodenhuis S, van der Graaf W, et al. Imatinib mesylate (STI-571 Glivec, Gleevec) is an active agent for gastrointestinal stromal tumours, but does not yield responses in other soft tissue sarcomas that are unselected for a molecular target: results from an EORTC Soft Tissue and Bone Sarcoma Group phase II study. Eur J Cancer. 2003;39:2006–11.PubMedCrossRefGoogle Scholar
  55. 55.
    Blay J-Y, von Mehren M, Blackstein ME. Perspective on updated treatment guidelines for patients with gastrointestinal stromal tumors. Cancer. 2010;116:5126–37.PubMedPubMedCentralCrossRefGoogle Scholar
  56. 56.
    Antonescu CR, Yoshida A, Guo T, Chang N-E, Zhang L, Agaram NP, et al. KDR activating mutations in human angiosarcomas are sensitive to specific kinase inhibitors. Cancer Res. 2009;69:7175–9.PubMedPubMedCentralCrossRefGoogle Scholar
  57. 57.
    Yudoh K, Kanamori M, Ohmori K, Yasuda T, Aoki M, Kimura T. Concentration of vascular endothelial growth factor in the tumour tissue as a prognostic factor of soft tissue sarcomas. Br J Cancer. 2001;84:1610–5.PubMedPubMedCentralCrossRefGoogle Scholar
  58. 58.
    Tomich J, Grove Nigro K, Barr RG. Primary angiosarcoma of the breast: a case report and review of the literature. Ultrasound Q. 2017;33(1):46–8.PubMedCrossRefGoogle Scholar
  59. 59.
    Iacoponi S, Calleja J, Hernandez G, Sainz de la Cuesta R. Primary breast angiosarcoma in a young woman. Int J Surg Case Rep 2016;24:101–103.PubMedPubMedCentralCrossRefGoogle Scholar
  60. 60.
    Blanchard DK, Reynolds CA, Grant CS, Donohue JH. Primary nonphylloides breast sarcomas. Am J Surg. 2003;186:359–61.PubMedCrossRefGoogle Scholar
  61. 61.
    Wakwlu PE Jr. Mesenchymal neoplasms of the breast. In: Bland KI, Copeland EM, editors. The breast. Comprehensive management of benign and malignant disease. IVth ed. Philadelphia: Saunders/Elsevier; 2009. p. 261–9.Google Scholar
  62. 62.
    Agarwal PK, Mehrotra R. Haemangiosarcoma of the breast. Indian J Cancer. 1977;14(2):182–5.PubMedGoogle Scholar
  63. 63.
    Myerowitz RL, Pietruszka M, Barnes EL. Primary angiosarcoma of the breast. JAMA. 1978;239(5):403.PubMedCrossRefGoogle Scholar
  64. 64.
    Arora TK, Terracina KP, Soong J, Idowu MO, Takabe K. Primary and secondary angiosarcoma of the breast. Gland Surg. 2014;3:28–34.PubMedPubMedCentralGoogle Scholar
  65. 65.
    Guo T, Zhang L, Chang NE, Singer S, Maki RG, Antonescu CR. Consistent MYC and FLT4 gene amplification in radiation-induced angiosarcoma but not in other radiation-associated atypical vascular lesions. Genes Chromosomes Cancer. 2011;50:25–33.PubMedPubMedCentralCrossRefGoogle Scholar
  66. 66.
    Fodor J, Orosz Z, Szabo E, Sulyok Z, Polgar C, Zaka Z, et al. Angiosarcoma after conservation treatment for breast carcinoma: our experience and a review of the literature. J Am Acad Dermatol. 2006;54:499–504.PubMedCrossRefGoogle Scholar
  67. 67.
    Sheth GR, Cranmer LD, Smith BD, Grasso-Lebeau L, Lang JE. Radiation-induced sarcoma of the breast: a systematic review. Oncologist. 2012;17:405–18.PubMedPubMedCentralCrossRefGoogle Scholar
  68. 68.
    Fowble B, Hanlon A, Freedman G, Nicolaou N, Anderson P. Second cancers after conservative surgery and radiation for stage I–II breast cancer: identifying a subset of women at increased risk. Int J Radiat Oncol Biol Phys. 2001;51:679–90.PubMedCrossRefGoogle Scholar
  69. 69.
    Huang J, Mackillop WJ. Increased risk of soft tissue sarcoma after radiotherapy in women with breast carcinoma. Cancer. 2001;92:172–80.PubMedCrossRefGoogle Scholar
  70. 70.
    Freedman GM. Radiation complications and their treatment. In: Bland KI, Copeland EM, editors. The breast. Comprehensive management of benign and malignant disease. IVth ed. Philadelphia: Saunders/Elsevier; 2009. p. 1113–22.Google Scholar
  71. 71.
    Billings SD, McKenney JK, Folpe AL, Hardacre MC, Weiss SW. Cutaneous angiosarcoma following breast-conserving surgery and radiation. An analysis of 27 cases. Am J Surg Pathol. 2004;28:781–8.PubMedCrossRefGoogle Scholar
  72. 72.
    Montoe AT, Feigenberg SJ, Mendenhall NP. Angiosarcoma after breast-conserving therapy. Cancer. 2003;97:1832–40.CrossRefGoogle Scholar
  73. 73.
    Peterson CB, Beauregard S. Radiation-Induced Breast Angiosarcoma: Case Report and Clinical Approach. J Cutan Med Surg. 2016;20(4):304–7.PubMedCrossRefGoogle Scholar
  74. 74.
    Hodgson NC, Bowen-Wells C, Moffat F, Franceschi D, Avisar E. Angiosarcoma of the breast: a review of 70 cases. Am J Clin Oncol. 2007;30(6):570–3.PubMedCrossRefGoogle Scholar
  75. 75.
    Brenn T, Fletcher CDM. Radiation- associated cutaneous atypical vascular lesions and angiosarcoma. Clinicopathologic analysis of 42 cases. Am J Surg Pathol. 2005;29:983–6.PubMedGoogle Scholar
  76. 76.
    Zemanova M, Machalekova K, Sandorova M, Boljesikova E, Skultetyova M, Svec J, Zeman A. Clinical management of secondary angiosarcoma after breast conservation therapy. Rep Pract Oncol Radiother. 2014;19(1):37–46.PubMedCrossRefGoogle Scholar
  77. 77.
    Zeng W, Styblo TM, Li S, Sepulveda JN, Schuster DM. Breast angiosarcoma. FDG PET findings. Clin Nucl Med. 2009;34:443–5.PubMedCrossRefGoogle Scholar
  78. 78.
    Gambini D, Visintin R, Locatelli E, Bareggi C, Galassi B, Runza L, et al. Secondary breast angiosarcoma and paclitaxel-dependent prolonged disease control: report of two cases and review of the literature. Tumori. 2015;101:e60. [Epub ahead of print].CrossRefPubMedGoogle Scholar
  79. 79.
    Hillenbrand T, Menge F, Hohenberger P, Kasper B. Primary and secondary angiosarcomas: a comparative single-center analysis. Clin Sarcoma Res. 2015;5:14.PubMedPubMedCentralCrossRefGoogle Scholar
  80. 80.
    Ghareeb ER, Bhargava R, Vargo JA, Florea AV, Beriwal S. Primary and radiation-induced breast angiosarcoma Clinicopathologic predictors of outcomes and the impact of adjuvant radiation therapy. Am J Clin Oncol. 2016;39(5):463–7.PubMedCrossRefGoogle Scholar
  81. 81.
    Rosen PP, Kimmel M, Ernsberge D. Mammary angiosarcoma. The prognostic significance of tumor differentiation. Cancer. 1998;62:2145–51.CrossRefGoogle Scholar
  82. 82.
    Yadav SK, Yadav J, Abhinav A, Satish K, Om P, Manish K, Anjana G. Ulcerated primary fibrosarcoma of breast: case report and review of literature. Breast Dis. 2015;35(1):41–4.PubMedCrossRefGoogle Scholar
  83. 83.
    Deodhar SD, Khope SS, Kinare SG. Fibrosarcoma of the breast (a case report). J Postgrad Med. 1983;29:122–4.Google Scholar
  84. 84.
    Kijima Y, Umekita Y, Yoshinaka H, Taguchi S, Owaki T, Funasako Y, et al. Stromal sarcoma with features of giant cell malignant fibrous histiocytoma. Breast Cancer. 2007;14:239–44.PubMedCrossRefGoogle Scholar
  85. 85.
    Jones MW, Norris HJ, Wargotz ES, Weiss SW. Fibrosarcoma-malignant fibrous histiocytoma of the breast. A clinicopathologic study of 32 cases. Am J Surg Pathol. 1992;16:667–74.PubMedCrossRefGoogle Scholar
  86. 86.
    Cheah AL, Billings SD, Rowe JJ. Mesenchymal tumours of the breast and their mimics: a review with approach to diagnosis. Pathology. 2016;48(5):406–24.PubMedCrossRefGoogle Scholar
  87. 87.
    Salemis NS. Intramuscular atypical lipomatous tumor/well-differentiated liposarcoma of the pectoralis major masquerading as a breast tumor: management and review of the literature. Int Surg. 2015;100:194–8.PubMedPubMedCentralCrossRefGoogle Scholar
  88. 88.
    Sancheti SM, Sawaimoon SK, Ahmed R. Pleomorphic liposarcoma arising in a malignant phyllodes tumor of breast: a rare occurrence. J Cancer Res Ther. 2015;11:1032.PubMedCrossRefGoogle Scholar
  89. 89.
    Vera-Alvarez J, Marigil-Gomez M, Abascal-Agorreta M, Garcia-Prats MD, Lopez-Lopez JI, Perez-Ruiz J. Malignant phyllodes tumor with pleomorphic liposarcomatous stroma diagnosed by fine needle aspiration cytology: a case report. Acta Cytol. 2002;46:50–6.PubMedCrossRefGoogle Scholar
  90. 90.
    Cimino-Mathews A, Subhawong AP, Elwood H, Warzecha HN, Sharma R, Park BH, Taube JM, Illei PB, Argani P. Neural crest transcription factor Sox10 is preferentially expressed in triple- negative and metaplastic breast carcinomas. Hum Pathol. 2013;44:959–65.PubMedCrossRefGoogle Scholar
  91. 91.
    Powell CM, Rosen PP. Adipose differentiation in cystosarcoma phyllodes. A study of 14 cases. Am J Surg Pathol. 1994;18:720–7.PubMedCrossRefGoogle Scholar
  92. 92.
    Charfi L, Driss M, Mrad K, Abbes I, Dhouib R, Sassi S, et al. Primary well differentiated liposarcoma: an unusual tumor in the breast. Breast J. 2009;15:206–7.PubMedCrossRefGoogle Scholar
  93. 93.
    Falconieri G, Della Libera D, Zanconati F, Bittesini L. Leiomyosarcoma of the female breast. Report of two new cases and review of the literature. Am J Clin Pathol. 1997;108:19–25.PubMedCrossRefGoogle Scholar
  94. 94.
    Parham DM, Robertson AJ, Hussein KA, Davidson AI. Leiomyosarcoma of the breast: cytological and histological features with a review of the literature. Cytopathology. 1992;3:245–52.PubMedCrossRefGoogle Scholar
  95. 95.
    Hays DM, Donaldson SS, Shimada H, Crist WM, Newton WA Jr, Andrassy RJ, et al. Primary and metastatic rhabdomyosarcoma in the breast: neoplasms of adolescent females, a report from the intergroup Rhabdomyosarcoma study. Med Pediatr Oncol. 1997;29:181–9.PubMedCrossRefGoogle Scholar
  96. 96.
    Crist WM, Anderson JR, Meza JL, Fryer C, Raney RB, Ruymann FB, et al. Intergroup rhabdomyosarcoma study IV: results for patients with nonmetastatic disease. J Clin Oncol. 2001;19:3091–102.PubMedCrossRefGoogle Scholar
  97. 97.
    Audino AN, Setty BA, Yeager ND. Rhabdomyosarcoma of the breast in adolescent and young adult (AYA) women. J Pediatr Hematol Oncol. 2017;39(1):62–6.PubMedCrossRefGoogle Scholar
  98. 98.
    Herzog CE. Overview of sarcomas in the adolescent and young adult population. J Pediatr Hematol Oncol. 2005;27:215–8.PubMedCrossRefGoogle Scholar
  99. 99.
    Lynch HT, Marcud JN, Lynch J, Snyder CL, Rubinstein WS. Breast cancer genetics: syndromes, genes, pathology, counseling, testing and treatment. In: Bland KI, Copeland EM, editors. The breast. Comprehensive management of benign and malignant disease. IVth ed. Philadelphia: Saunders/Elsevier; 2009. p. 371–415.Google Scholar
  100. 100.
    Lynch HT, Mulcahy GM, Harris RE, Guirgis HA, Lynch JF. Genetic and pathologic findings in a kindred with hereditary sarcoma, breast cancer, brain tumors, leukemia, lung, laryngeal, and adrenal cortical carcinoma. Cancer. 1978;41:2055–64.PubMedCrossRefGoogle Scholar
  101. 101.
    Li FP, Fraumeni JF. Soft-tissue sarcomas, breast cancer, and other neoplasms: a familial syndrome? Ann Intern Med. 1969;71:747–52.PubMedCrossRefGoogle Scholar
  102. 102.
    Lynch HT, McComb RD, Osborn NK, Wolpert PA, Lynch JF, Wszolek ZK, et al. Predominance of brain tumors in an extended Li-Fraumeni (SBLA) kindred including a case of Sturge-Weber syndrome. Cancer. 2000;88:433–9.PubMedCrossRefGoogle Scholar
  103. 103.
    Liaw D, Marsh DJ, Li J, Dahia PL, Wang SI, Zheng Z, et al. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet. 1997;16:64–7.PubMedCrossRefGoogle Scholar
  104. 104.
    Nelen MR, van Stavernen WC, Peeters EA, Hassel MB, Gorlin RJ, Hamm H, et al. Germline mutations in the PTEN/MMAC1 gene in patients with Cowden disease. Hum Mol Genet. 1997;6:1383–7.PubMedCrossRefGoogle Scholar
  105. 105.
    Williard W, Borgen P, Bol R, Tiwari R, Osborne M. Cowden’s disease: a case report with analysis at the molecular level. Cancer. 1992;69:2969–74.PubMedCrossRefGoogle Scholar
  106. 106.
    Schrager CA, Schneider D, Gruener AC, Tsou HC, Peacocke M. Clinical and pathological features of breast disease in Cowden’s syndrome: an underrecognized syndrome with an increased risk of breast cancer. Hum Pathol. 1998;29:47–53.PubMedCrossRefGoogle Scholar
  107. 107.
    Karlin NJ. Breast lymphoma. In: Bland KI, Copeland EM, editors. The breast. Comprehensive management of benign and malignant disease. IVth ed. Philadelphia: Saunders/Elsevier; 2009. p. 315–20.Google Scholar
  108. 108.
    Vignot S, Ledoussal V, Nodio P, Bourguignat A, Janvier M, Mounier N, et al. Non-Hodgkin’s lymphoma of the breast. A report of 19 cases and review of the literature. Clin Lymphoma. 2005;6:37–42.PubMedCrossRefGoogle Scholar
  109. 109.
    Liu MT, Hsieh CY, Wang AY, Pi CP, Chang TH, Huang CC, et al. Primary breast lymphoma: a pooled analysis of prognostic factors and survival in 93 cases. Ann Saudi Med. 2005;25:288–93.PubMedPubMedCentralCrossRefGoogle Scholar
  110. 110.
    Choo SP, Lim ST, Wong EH, Tao M. Breast lymphoma: favorable prognosis after treatment with standard combination chemotherapy. Onkologie. 2006;29:4–18.Google Scholar
  111. 111.
    Ryan GF, Roos DR, Seymour JF. Primary non-Hodgkin’s lymphoma of the breast: retrospective analysis of prognosis and patterns of failure in two Australian centers. Clin Lymphoma Myeloma. 2006;6:337–41.PubMedCrossRefGoogle Scholar
  112. 112.
    Aviles A, Selgado S, Nambo MJ, Neri N, Murillo E, Cleto S. Primary breast lymphoma: results of a controlled clinical trial. Oncology. 2005;69:256–60.PubMedCrossRefGoogle Scholar
  113. 113.
    Dixon JM, Lumsden AB, Krajewski A, Elton RA, Anderson TJ. Primary lymphoma of the breast. Br J Surg. 1987;74:214–6.PubMedCrossRefGoogle Scholar
  114. 114.
    Fruchart C, Denoux Y, Chaste J, Peny AM, Boute V, Ollivier JM, et al. High grade primary breast lymphoma: is it a different clinical entity? Breast Cancer Res Treat. 2005;93:91–8.CrossRefGoogle Scholar
  115. 115.
    Ganjoo K, Advani R, Mariappan M, McMillan A, Horning S. Non-Hodgkin’s lymphoma of the breast. Cancer. 2007;110:25–30.PubMedCrossRefGoogle Scholar
  116. 116.
    Cheah CY, Campbell BA, Seymour JF. Primary breast lymphoma. Cancer Treat Rev. 2014;40:900–8.PubMedCrossRefGoogle Scholar
  117. 117.
    Mpallas G, Simatos G, Tadidou A, Patra E, Galateros G, Lakiotis G, et al. Primary breast lymphoma in a male patient. Breast. 2004;13:436–8.PubMedCrossRefGoogle Scholar
  118. 118.
    Hong JW, Zhong YW. Treatment situation of primary breast lymphoma. Zhongguo Xiandai Putong Waike Jinzhan. 2007;10:513–5.Google Scholar
  119. 119.
    Lyons JA, Myles J, Pohlman B, Macklis RM, Crowe J, Crownover RL. Treatment of prognosis of primary breast lymphoma: a review of 13 cases. Am J Clin Oncol. 2000;23:334–6.PubMedCrossRefGoogle Scholar
  120. 120.
    Yang WT, Lane DL, Le-Petross HT, Abruzzo LV, Macapinlac HA. Breast lymphoma: imaging findings of 32 tumors in 27 patients. Radiology. 2007;245:692–702.PubMedCrossRefGoogle Scholar
  121. 121.
    Vasilaki T, Zizi-Sermpetzoglou A, Katsamagkou E, Grammatoglou X, Petrakopoulou N, Glava C. Bilateral primary breast lymphoma. A case report. Eur J Gynaecol Oncol. 2006;27:623–4.Google Scholar
  122. 122.
    Yang H, Lang RG, Fu L. Primary breast lymphoma (PBL): a literature review. Clin Oncol Cancer Res. 2011;8:128–32.CrossRefGoogle Scholar
  123. 123.
    Bishara MR, Ross C, Sur M. Primary anaplastic large cell lymphoma of the breast arising in reconstruction mammoplasty capsule of saline filled breast implant after radical mastectomy for breast cancer: an unusual case presentation. Diagn Pathol. 2009;4:11–6.PubMedPubMedCentralCrossRefGoogle Scholar
  124. 124.
    Newman MK, Zemmel NJ, Bandak AZ, Kaplan BJ. Primary breast lymphoma in a patient with silicone breast implants: a case report and review of the literature. J Plast Reconstr Aesthet Surg. 2008;61:822–5.PubMedCrossRefGoogle Scholar
  125. 125.
    Dan L, Can M, Qingming J. Primary breast diffuse large B cell lymphoma: a clinicopathologic study of twelve cases. Chongqing Yike Daxue Xuebao. 2009;34:650–3.Google Scholar
  126. 126.
    Zucca E, Conconi A, Mughal TI, Sarris AH, Seymour JF, Vitolo U, et al. Patterns of outcome and prognostic factors in primary large-cell lymphoma of the testis in a survey by the International Extranodal Lymphoma Study Group. J Clin Oncol. 2003;21:20–7.PubMedCrossRefGoogle Scholar
  127. 127.
    Ryan G, Martinelli G, Kuper-Hommel M, Tsang R, Pruneri G, Yuen K, et al. Primary diffuse large B-cell lymphoma of the breast: prognostic factors and outcomes of a study by the International Extranodal Lymphoma Study Group. Ann Oncol. 2008;19:233–41.PubMedCrossRefGoogle Scholar
  128. 128.
    Giron GL, Hamlin PA, Brogi E, Mendez JE, Sciafani L. Primary lymphoma of the breast: a case of marginal zone B-cell lymphoma. Am Surg. 2004;70:720–5.PubMedGoogle Scholar
  129. 129.
    Woo O, Yong H, Dhin B, Park CM, Kang EY. Synchronous bilateral primary breast lymphoma: MRI and pathologic findings. Breast J. 2007;13:429–30.PubMedCrossRefGoogle Scholar
  130. 130.
    Kuroaüda H, Tamaru J, Takeuchi I, Ohnisi K, Toyozumi Y, Momose S, et al. Primary diffuse large B-cell lymphoma of the breast. Breast Cancer. 2007;14:317–22.CrossRefGoogle Scholar
  131. 131.
    Lamovee J, Jancar J. Primary malignant lymphoma of the breast. Cancer. 1987;60:3033–41.CrossRefGoogle Scholar
  132. 132.
    Lihara K, Yamaguchi K, Nishimura Y, Iwasaki T, Suzuki K, Hirabayashi Y. Spontaneous regression of malignant lymphoma of the breast. Pathol Int. 2004;54:537–42.CrossRefGoogle Scholar
  133. 133.
    Karim RZ, Scolyer RA, Tse GM, Tan PH, Putti TC, Lee CS. Pathogenic mechanisms in the initiation and progression of mammary phyllodes tumours. Pathology. 2009;41:105–17.PubMedCrossRefGoogle Scholar
  134. 134.
    Sitzenfrey A. Mammakarzinom zwei jahre nach abdominaler radikal operation wegen doppelseitigen carcinoma ovarii. Prag Med Wochenschr. 1907;32:221–35.Google Scholar
  135. 135.
    Madan AK, Ternovits C, Huber SA, Pei LA, Jaffe BM. Gastrointestinal metastasis to the breast. Surgery. 2002;132:889–93.PubMedCrossRefGoogle Scholar
  136. 136.
    Klingen TA, Klaasen H, Aas H, Chen Y, Akslen LA. Secondary breast cancer: a 5-year population-based study with review of the literature. APMIS. 2009;117:762–7.PubMedCrossRefGoogle Scholar
  137. 137.
    Magri K, Demoulin G, Millon G, Duvert B. Metastasis to the breast from non mammary metastasis. Clinical, radiological characteristics and diagnostic process. A report of two cases and a review of literature. J Gynecol Obstet Biol Reprod. 2007;36:602–6.CrossRefGoogle Scholar
  138. 138.
    Majeski J. Bilateral masses as initial presentation of widely metastatic melanoma. J Surg Oncol. 1999;72:175–7.PubMedCrossRefGoogle Scholar
  139. 139.
    Moschetta M, Telegrafo M, Lucarelli NM, Martino G, Rella L, Stabile Ianora AA, et al. Metastatic breast disease from cutaneous malignant melanoma. Int J Surg Case Rep. 2014;5:34–6.PubMedCrossRefGoogle Scholar
  140. 140.
    Ho LW, Wong KP, Chan JH, Chow LW, Leung EY, Leong L. MR appearance of metastatic melanotic melanoma in breast. Clin Radiol. 2000;55:572–3.PubMedCrossRefGoogle Scholar
  141. 141.
    Mayayo AE, Gomez-Aracil V, Mayayo AR, Azua-Romeo A. Spindle cell malignant melanoma metastatic to the breast from pigmented lesion on the back. A case report. Acta Cytol. 2004;48:387–90.CrossRefGoogle Scholar
  142. 142.
    Arora R, Robinson W. Breast metastases from malignant melanoma. J Surg Oncol. 1992;50:27–9.PubMedCrossRefGoogle Scholar
  143. 143.
    Maounis N, Chorti M, Legaki S, Ellina E, Emmanouilidou A, Demonakou M, Tsiafaki X. Metastasis to the breast from an adenocarcinoma of the lung with extensive micropapillary component: a case report and review of the literature. Diagn Pathol. 2010;17(5):82.CrossRefGoogle Scholar
  144. 144.
    Williams SA, Ehlers RA, Hunt KK, Yi M, Kuerer HM, Singletary SE, et al. Metastases to the breast from nonbreast solid neoplasms: presentation and determinants of survival. Cancer. 2007;110:731–7.PubMedCrossRefGoogle Scholar
  145. 145.
    Vizcaíno I, Torregrosa A, Higueras V, Morote V, Cremades A, Torres V, et al. Metastasis to the breast from extramammary malignancies: a report of four cases and a review of literature. Eur Radiol. 2001;11:1659–65.PubMedCrossRefGoogle Scholar
  146. 146.
    Noguera JJ, Martínez-Miravete P, Idoate F, Diaz L, Pina L, Zornoza G, et al. Metastases to the breast: a review of 33 cases. Australas Radiol. 2007;51:133–8.PubMedCrossRefGoogle Scholar
  147. 147.
    Gómez-Caro A, Piñero A, Roca MJ, Torres J, Ferri B, Galindo PJ, et al. Surgical treatment of solitary metastasis in the male breast from non-small cell lung cancer. Breast J. 2006;12:366–7.PubMedCrossRefGoogle Scholar
  148. 148.
    Lee AHS. The histological diagnosis of metastases to the breast from extramammary malignancies. J Clin Pathol. 2007;60:1333–41.PubMedPubMedCentralCrossRefGoogle Scholar
  149. 149.
    Hamby LS, McGrath PC, Cibull ML, Schwartz RW. Gastric carcinoma metastatic to the breast. J Surg Oncol. 1991;48:117–21.PubMedCrossRefGoogle Scholar
  150. 150.
    Boutis AL, Andreadis C, Patakiouta F, Mouratidou D. Gastric signet-ring adenocarcinoma presenting with breast metastasis. World J Gastroenterol. 2006;12:2958–61.PubMedPubMedCentralCrossRefGoogle Scholar
  151. 151.
    Yeh CN, Lin CH, Chen MF. Clinical and ultrasonographic characteristics of breast metastases from extramammary malignancies. Am Surg. 2004;70:287–90.PubMedGoogle Scholar
  152. 152.
    Kwak JY, Kim EK, Oh KK. Radiologic findings of metastatic signet ring cell carcinoma to the breast from stomach. Yonsei Med J. 2000;41:669–72.PubMedCrossRefGoogle Scholar
  153. 153.
    Lee SK, Kim WW, Kim SH, Hur SM, Kim S, Choi JH, et al. Characteristics of metastasis in the breast from extramammary malignancies. J Surg Oncol. 2010;101:137–40.PubMedCrossRefGoogle Scholar
  154. 154.
    Verger E, Conill C, Velasco M, Sole M. Metastasis in the male breast from a lung adenocarcinoma. Acta Oncol. 1992;31:479.PubMedCrossRefGoogle Scholar
  155. 155.
    Chaignaud B, Hall TJ, Powers C, Subramony C, Scott-Conner CE. Diagnosis and natural history of extramammary tumors metastatic to the breast. J Am Coll Surg. 1994;179:49–53.PubMedGoogle Scholar
  156. 156.
    Alvarado Cabrero I, Carrera Alvarez M, Perez Montiel D, Tavassoli FA. Metastases to the breast. Eur J Surg Oncol. 2003;29:854–5.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Gursel Remzi Soybir
    • 1
  1. 1.Department of General Surgery, Istanbul Memorial HospitalIstanbulTurkey

Personalised recommendations